🔗 Share this article

Texas Attorney General Paxton is taking legal action against the manufacturers of acetaminophen, alleging the firms withheld alleged dangers that the medication created to children's neurological development.

This legal action follows four weeks after Former President Trump advocated an unproven link between taking Tylenol - also known as acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is filing suit against the pharmaceutical giant, which formerly manufactured the medication, the only pain reliever suggested for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he claimed they "misled consumers by gaining financially from pain and marketing drugs ignoring the risks."

The manufacturer asserts there is insufficient reliable data tying acetaminophen to autism.

"These corporations lied for decades, deliberately risking numerous people to boost earnings," Paxton, a Republican, stated.

The company said in a statement that it was "seriously troubled by the spread of false claims on the security of paracetamol and the possible consequences that could have on the well-being of women and children in America."

On its official site, the company also said it had "continuously evaluated the pertinent research and there is lacking reliable evidence that demonstrates a verified association between using paracetamol and autism spectrum disorder."

Groups acting on behalf of medical professionals and medical practitioners concur.

The leading OB-GYN organization has stated paracetamol - the key substance in acetaminophen - is a restricted selection for pregnant women to manage discomfort and elevated temperature, which can create serious health risks if ignored.

"In more than two decades of studies on the utilization of paracetamol in pregnancy, not a single reputable study has definitively established that the use of acetaminophen in any trimester of gestation leads to neurological conditions in offspring," the organization said.

The court filing mentions current declarations from the Trump administration in claiming the medication is reportedly hazardous.

Last month, the former president generated worry from public health officials when he told expectant mothers to "fight like hell" not to take acetaminophen when sick.

The US Food and Drug Administration then released a statement that doctors should consider limiting the use of Tylenol, while also declaring that "a proven link" between the drug and autism spectrum disorder in young ones has remains unverified.

The Health Department head Robert F Kennedy Jr, who oversees the Food and Drug Administration, had pledged in spring to conduct "a massive testing and research effort" that would establish the source of autism in a matter of months.

But specialists warned that discovering a unique factor of autism spectrum disorder - believed by scientists to be the outcome of a intricate combination of inherited and environmental factors - would be difficult.

Autism spectrum disorder is a form of lifelong neurodivergence and impairment that impacts how individuals experience and relate to the environment, and is identified using physician assessments.

In his lawsuit, the attorney general - a Trump ally who is campaigning for the Senate - alleges the manufacturer and Johnson & Johnson "willfully ignored and attempted to silence the research" around paracetamol and autism.

This legal action seeks to make the companies "destroy any promotional materials" that states acetaminophen is reliable for expectant mothers.

The court case mirrors the complaints of a group of mothers and fathers of children with autism spectrum disorder and ADHD who took legal action against the manufacturers of Tylenol in two years ago.

Judicial authorities rejected the lawsuit, declaring research from the family's specialists was not conclusive.